Insulin-Like Growth Factor-I-Forkhead Box O Transcription Factor 3a Counteracts High Glucose/Tumor Necrosis Factor-alpha-Mediated Neuronal Damage: Implications for Human Immunodeficiency Virus Encephalitis Article

Full Text via DOI: 10.1002/jnr.22542 PMID: 21162126 Web of Science: 000285456400007

Cited authors

  • Wilk, Anna; Urbanska, Katarzyna; Yang, Shuo; Wang, Jin Ying; Amini, Shohreh; Del Valle, Luis; Peruzzi, Francesca; Meggs, Leonard; Reiss, Krzysztof

Abstract

  • In HIV patients, antiretroviral medications trigger metabolic abnormalities, including insulin resistance. In addition, the inflammatory cytokine tumor necrosis factor-alpha (TNF alpha), which is elevated in human immunodeficiency virus encephalitis (HIVE), also induces insulin resistance and inflicts neuronal damage in vitro. In differentiated PC12 cells and rat cortical neurons, high glucose (HG; 25 mM) triggers reactive oxygen species (ROS) accumulation, contributing to the retraction of neuronal processes, with only a minimal involvement of neuronal apoptosis. In the presence of TNF alpha, HG-treated neurons undergo massive apoptosis. Because mammalian homolog of the Forkhead family of transcription factors, Forkhead box O transcription factor 3a (FOXO3a), controls ROS metabolism, we asked whether FOXO3a could affect the fate of differentiated neurons in the paradigm of HIVE. We observed FOXO3a nuclear translocation in HG-treated neuronal cultures, accompanied by partial loss of mitochondrial potential and gradual retraction of neuronal processes. Addition of TNF alpha to HG-treated neurons increased expression of the FOXO-dependent proapoptotic gene Bim, which resulted in extensive apoptotic death. Insulin-like growth factor-I (IGF-I) significantly lowered intracellular ROS, which was accompanied by IGF-I-mediated FOXO3a nuclear export and decrease in its transcriptional activity. The clinical relevance of these findings is supported by detection of nuclear FOXO3a in TUNEL-positive cortical neurons from HIVE, especially in brain areas characterized by elevated TNF alpha. (C) 2010 Wiley-Liss, Inc.

Publication date

  • 2011

Published in

Category

International Standard Serial Number (ISSN)

  • 0360-4012

Start page

  • 183

End page

  • 198

Volume

  • 89

Issue

  • 2